A novel and innovative approach to treating metastasized cancer, starting with the very lethal grade 4 pancreatic cancer. Earlier this year, scientists from Columbia University in New York demonstrated that the growth rate of pancreatic ...
Read MoreSAN ?WANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) -- Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU. As a bioequivalent version of Victoza ® pre-filled pen, ...
Read MoreTAIPEI, Taiwan, June 12, 2024 (GLOBE NEWSWIRE) -- OBI Pharma, a clinical-stage oncology company (4174.TWO), today announced the initiation of a Phase 1/2 clinical trial of OBI-992, an antibody-drug conjugate (ADC) targeting TROP2 (Trophoblast ...
Read MoreSAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Academy ...
Read MoreANYANG, South Korea , Nov. 29, 2019 /PRNewswire/ -- Vieworks, a global leader in X-ray imaging solution, is showcasing the newest DR detector lineup featuring the advanced imaging technology at RSNA 2019 (South hall #1723) from 1 to 6 December ...
Read MoreSHENZHEN, China , Nov. 29, 2019 /PRNewswire/ -- On November 29, 2019 , Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company's lead innovative product Epidaza® (Chidamide), an ...
Read MoreNJ Top Doc, Dr. Paul Kovatis continues to display expertise and leadership in the field of orthopedic foot and ankle surgery. SCOTCH PLAINS, N.J. , Nov. 29, 2019 /PRNewswire-PRWeb/ -- NJ Top Doc, Paul Kovatis , MD has been in private ...
Read MoreHANGZHOU , China and SHAOXING, China , Nov. 28, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, ...
Read MoreSHANGHAI and SEOUL, South Korea , Nov. 28, 2019 /PRNewswire/ -- WuXi ATU Co., Ltd., (WuXi ATU) - a subsidiary of WuXi AppTec, and GeneMedicine - a South Korea -based gene therapy biotechnology company, have formed a strategic partnership for ...
Read MoreChair Craig Wallentine says ISEA, "will stay focused on needs of end users to identify and implement safety innovations to protect more workers." ARLINGTON, Va. , Nov. 28, 2019 /PRNewswire-PRWeb/ -- Craig Wallentine , Global Business ...
Read MoreLAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 28, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ( " Liminal BioSciences " or the "Company " ), a clinical-stage biopharmaceutical company focused on ...
Read MoreAppoints Leah Olson-Friesen Chief Operating Officer REGINA , Nov. 28, 2019 /CNW/ - Lumeca Health, one of Canada's leading virtual healthcare platforms, is proud to announce the appointment of Leah Olson-Friesen to the role of Chief ...
Read MoreSubscribe to our Free Newsletters!